News Website

Mesonephric-like Adenocarcinoma (MLA) Diagnostic Criteria and Controversies: Perspectives and Guidance From Pathologists in the MLA Consortium.

Mesonephric-like adenocarcinoma (MLA) is a rare and aggressive gynecologic malignancy that has only been recognized in the last decade. It arises in the endometrium, ovaries, and other extrauterine sites (often …

Published: Nov. 24, 2025, midnight

Read Full Article

MLA endometrial cancer endometrial carcinoma extrauterine carcinoma gynecologic cancer gynecologic carcinoma mesonephric carcinoma mesonephric-like carcinoma ovarian cancer ovarian carcinoma

Peritoneal Inclusion Cyst Mimicking Peritoneal Carcinomatosis: A Benign Lesion Posing a Malignant Dilemma - Cureus

Peritoneal Inclusion Cyst Mimicking Peritoneal Carcinomatosis: A Benign Lesion Posing a Malignant Dilemma Cureus

Published: Nov. 20, 2025, 6:22 a.m.

Read Full Article

Therapeutic targeting of interleukin-17C signaling in carcinogenesis of endometriosis.

Endometriosis-associated ovarian carcinoma (EAOC) predominantly arises from the malignant transformation of endometriomas, yet the mechanism is incompletely defined. Spatial transcriptomic analysis of human specimens of normal endometrium, endometriomas, and EAOC …

Published: Nov. 20, 2025, midnight

Read Full Article

IL-17C IL-17RE carcinogenesis endometriosis endometriosis-associated ovarian carcinoma

Association between endometriosis and prognosis of ovarian clear cell carcinoma: A systematic review and meta-analysis.

To examine if endometriosis affected outcomes of ovarian clear cell carcinoma (OCCC).

Published: Nov. 18, 2025, midnight

Read Full Article

Endometriosis Meta-analysis Mortality Ovarian neoplasms Prognosis Recurrence

FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - 뉴스와이어

FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma 뉴스와이어

Published: Nov. 13, 2025, 5:50 a.m.

Read Full Article

FDA Clears New CDx for Pembrolizumab/Lenvatinib in Endometrial Carcinoma - Targeted Oncology

FDA Clears New CDx for Pembrolizumab/Lenvatinib in Endometrial Carcinoma Targeted Oncology

Published: Nov. 12, 2025, 7:08 p.m.

Read Full Article

FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - BioSpace

FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma BioSpace

Published: Nov. 12, 2025, 4:01 a.m.

Read Full Article

Hysterectomy Status and Outcomes in Patients With Grade 1, Stage IA Endometrioid Adenocarcinoma - 2 Minute Medicine

Hysterectomy Status and Outcomes in Patients With Grade 1, Stage IA Endometrioid Adenocarcinoma 2 Minute Medicine

Published: Nov. 12, 2025, 12:07 a.m.

Read Full Article

Case Report: Diagnostic challenges in cervical small cell neuroendocrine carcinoma of a reproductive-age woman.

Small cell neuroendocrine carcinoma of the cervix (SCNEC) is a rare and highly aggressive malignancy with a poor prognosis. We report the case of a 36-year-old nulliparous woman with a …

Published: Nov. 10, 2025, midnight

Read Full Article

case report diagnosis prognostic factors small cell neuroendocrine carcinoma therapy uterine cervix

Presacral Clear Cell Carcinoma of Müllerian Origin 20 Years After Hysterectomy and Bilateral Salpingo-Oophorectomy: A Case Report and Literature Review.

Primary presacral clear cell carcinoma (CCC) of Müllerian origin is extremely rare. Malignant transformation of endometriosis is a known phenomenon, though typically involving the ovaries or pelvic peritoneum. Retroperitoneal presentation, …

Published: Nov. 7, 2025, midnight

Read Full Article

clear cell carcinoma endometriosis ovarian clear cell carcinoma and endometriosis retroperitoneal clear cell carcinoma

Latest Articles

Mesonephric-like Adenocarcinoma (MLA) Diagnostic Criteria and Controversies: Perspectives and Guidance From Pathologists in the MLA Consortium.

Peritoneal Inclusion Cyst Mimicking Peritoneal Carcinomatosis: A Benign Lesion Posing a Malignant Dilemma - Cureus

Therapeutic targeting of interleukin-17C signaling in carcinogenesis of endometriosis.

Association between endometriosis and prognosis of ovarian clear cell carcinoma: A systematic review and meta-analysis.

FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - 뉴스와이어

FDA Clears New CDx for Pembrolizumab/Lenvatinib in Endometrial Carcinoma - Targeted Oncology

FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - BioSpace

Hysterectomy Status and Outcomes in Patients With Grade 1, Stage IA Endometrioid Adenocarcinoma - 2 Minute Medicine

Case Report: Diagnostic challenges in cervical small cell neuroendocrine carcinoma of a reproductive-age woman.

Presacral Clear Cell Carcinoma of Müllerian Origin 20 Years After Hysterectomy and Bilateral Salpingo-Oophorectomy: A Case Report and Literature Review.

Subscribe to Our Newsletter